Suppr超能文献

[结节性淋巴瘤的长期演变。1968年至1975年间接受治疗的85例患者的预后(作者译)]

[Long-term evolution of nodular lymphoma. Outcome in 85 patients treated between 1968 and 1975 (author's transl)].

作者信息

Dumont J, Asselain B, Weil M, Jacquillat C, Dana M, Chelloul N, Ripault J

出版信息

Nouv Presse Med. 1981 Jun 20;10(27):2261-5.

PMID:7022368
Abstract

Eighty-five patients with nodular lymphoma diagnosed between 1968 and 1975 were followed up for long periods and were treated by either conventional methods (local radiotherapy and single drug chemotherapy) or by more intensive therapeutic regimens, such as initial combined M.O.P.P. therapy and maintenance treatment with chlorambucil with or without further courses of M.O.P.P. Long-term follow-ups have brought to light some interesting points concerning the prognosis. Dissemination of the disease and large-cell histological pattern were, as already known, unfavourable factors. Neither age nor sex, nor bone-marrow involvement seemed to have any influence. Obtaining complete remissions improved the prognosis, but intensifying the initial and maintenance treatments proved disappointing: the survival rate remained the same, and the incidence of drug induced leukaemias was high. Indeed, relapses appeared to be less responsive to treatment when the patient had initially received multiple chemotherapy. However, in view of the high death rate of the disease (one-third of the patients in this series died within the first 5 years), trying new therapeutic regimens in the hope of obtaining better results, as has been done in Hodgkin's disease, would be fully justified.

摘要

对1968年至1975年间确诊的85例结节性淋巴瘤患者进行了长期随访,这些患者接受了传统方法(局部放疗和单药化疗)或更强化的治疗方案,如初始联合MOPP疗法以及使用苯丁酸氮芥进行维持治疗(有无进一步的MOPP疗程)。长期随访揭示了一些关于预后的有趣观点。正如已知的那样,疾病播散和大细胞组织学类型是不利因素。年龄、性别以及骨髓受累似乎均无影响。获得完全缓解可改善预后,但强化初始治疗和维持治疗的效果令人失望:生存率保持不变,且药物诱导白血病的发生率很高。实际上,当患者最初接受多种化疗时,复发似乎对治疗的反应较差。然而,鉴于该疾病的高死亡率(本系列中三分之一的患者在最初5年内死亡),像在霍奇金病中那样尝试新的治疗方案以期获得更好的结果是完全合理的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验